Page last updated: 2024-11-02

pinacidil and Coronary Disease

pinacidil has been researched along with Coronary Disease in 10 studies

Pinacidil: A guanidine that opens POTASSIUM CHANNELS producing direct peripheral vasodilatation of the ARTERIOLES. It reduces BLOOD PRESSURE and peripheral resistance and produces fluid retention. (Martindale The Extra Pharmacopoeia, 31st ed)

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
"We investigated the effect of ATP-sensitive K+ channel (KATP) openers (pinacidil and cromakalim), and a KATP blocker (glibenclamide) on reperfusion-induced arrhythmias in pentobarbitone-anaesthetized rats."3.69KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. ( Baczkó, I; Leprán, I; Papp, JG, 1997)
" In order to determine whether activation of adenosine triphosphate (ATP)-sensitive K+ channels exclusively explains the hypoxia- and ischaemia-induced action potential shortening, effects of tolbutamide and glibenclamide on changes in action potential duration (APD) during hypoxia, metabolic blockade or experimental ischaemia were examined in guinea-pig and canine isolated myocardium by standard microelectrode techniques."3.68Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium. ( Kanno, M; Nakaya, H; Takeda, Y; Tohse, N, 1991)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's6 (60.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miura, T1
Miki, T1
Baczkó, I1
Leprán, I1
Papp, JG1
Gojkoviíc Bukarica, L1
Kazić, T1
Sajić, Z1
Djukanović, B1
Panić, G1
Perić, M1
Bojić, M1
Chi, L1
Uprichard, AC1
Lucchesi, BR1
Bache, RJ1
Dai, XZ1
Baran, KW1
Cole, WC1
McPherson, CD1
Sontag, D1
Nakaya, H1
Takeda, Y1
Tohse, N1
Kanno, M1
Wolleben, CD1
Sanguinetti, MC1
Siegl, PK1
Grover, GJ1
McCullough, JR1
Henry, DE1
Conder, ML1
Sleph, PG1
Rockhold, FW1
Goldberg, MR1
Thompson, WL1

Reviews

1 review available for pinacidil and Coronary Disease

ArticleYear
ATP-sensitive K+ channel openers: old drugs with new clinical benefits for the heart.
    Current vascular pharmacology, 2003, Volume: 1, Issue:3

    Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Diazoxide; Glyburide; Human

2003

Trials

1 trial available for pinacidil and Coronary Disease

ArticleYear
Beneficial effects of pinacidil on blood lipids: comparisons with prazosin and placebo in patients with hypertension. Pinacidil-Prazosin and Pinacidil-Placebo Research Groups, Lilly Research Laboratories.
    The Journal of laboratory and clinical medicine, 1989, Volume: 114, Issue:6

    Topics: Antihypertensive Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic;

1989

Other Studies

8 other studies available for pinacidil and Coronary Disease

ArticleYear
KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
    European journal of pharmacology, 1997, Apr-11, Volume: 324, Issue:1

    Topics: Action Potentials; Adenosine Triphosphate; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Ar

1997
The effects of levcromakalim and pinacidil on the human internal mammary artery.
    Fundamental & clinical pharmacology, 1997, Volume: 11, Issue:6

    Topics: 4-Aminopyridine; Adenosine Triphosphate; Apamin; Charybdotoxin; Coronary Artery Bypass; Coronary Dis

1997
Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:3

    Topics: Action Potentials; Animals; Blood Pressure; Coronary Disease; Death, Sudden; Dogs; Dose-Response Rel

1990
Effect of pinacidil on myocardial blood flow in the presence of a coronary artery stenosis.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:4

    Topics: Animals; Antihypertensive Agents; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relati

1990
ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.
    Circulation research, 1991, Volume: 69, Issue:3

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Coronary Disease; Glyburide; Guanidines; Guinea

1991
Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium.
    British journal of pharmacology, 1991, Volume: 103, Issue:1

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Dogs; Fe

1991
Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts.
    Journal of molecular and cellular cardiology, 1989, Volume: 21, Issue:8

    Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Benzopyrans; Coronar

1989
Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 251, Issue:1

    Topics: Animals; Antihypertensive Agents; Benzopyrans; Coronary Disease; Cromakalim; Glyburide; Guanidines;

1989